Company Filing History:
Years Active: 1999-2004
Title: Harri Lonnberg: Innovator in Oligomer Technology
Introduction
Harri Lonnberg is a notable inventor based in Turku, Finland. He has made significant contributions to the field of oligomer technology, particularly in the development of functionalized oligomers for various applications. With a total of three patents to his name, Lonnberg's work has implications in diagnostics, therapeutics, and investigative research.
Latest Patents
Lonnberg's latest patents include innovations such as aminooxy functionalized oligomers and oligomer arrays. These inventions provide oligomers that are specifically hybridizable with selected sequences of RNA or DNA. Notably, at least one of the nucleoside moieties of these oligomers is modified to include an aminooxy linkage. This modification enhances their utility for diagnostic, therapeutic, and investigative purposes.
Career Highlights
Throughout his career, Harri Lonnberg has worked with prominent companies in the biotechnology sector. He has been associated with Isis Pharmaceuticals, Inc. and Glen Research Corporation, where he has contributed to advancing research and development in his field.
Collaborations
Lonnberg has collaborated with esteemed colleagues, including Muthiah Manoharan and Harri Salo. These partnerships have further enriched his research endeavors and have led to significant advancements in oligomer technology.
Conclusion
Harri Lonnberg's innovative work in oligomer technology has positioned him as a key figure in the field. His patents reflect a commitment to enhancing diagnostic and therapeutic methods through advanced scientific research.